| Bioactivity | Cefilavancin (TD-1792) is a potent multivalent glycopeptide-cephalosporin heterodimer antibiotic with effective activity against Gram-positive bacteria. Cefilavancin has been used to research skin infections[1][2][3]. |
| Invitro | Cefilavancin (TD-1792) has highly active against Methicillin-susceptible Staphylococcus aureus (MIC90 = 15 ng/mL), Methicillin-resistant Staphylococcus aureus, and heterogeneous Vancomycin-intermediate Staphylococcus aureus (MIC90 = 30 ng/mL)[1]. |
| Name | Cefilavancin |
| CAS | 1393900-12-3 |
| Formula | C87H95Cl3N16O28S2 |
| Molar Mass | 1983.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Cefilavancin
CAS: 1393900-12-3 F: C87H95Cl3N16O28S2 W: 1983.26
Cefilavancin (TD-1792) is a potent multivalent glycopeptide-cephalosporin heterodimer antibiotic with effective activity
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.